In an MNU-induced mouse GC model, we similarly observed a sharp decrease in CD54+ tsNeu levels from the time point of 12 weeks (early stage) to the time point of 24 weeks (late stage) (Fig. 2K). This evidence concerns the gene ICAM1 and gastric cancer.